D-α-tocopheryl polyethylene glycol 1000 succinate functionalized nanographene oxide for cancer therapy

Papers of special note have been highlighted as: • of interest

References

• 1 Cheng L, Wang C, Feng L, Yang K, Liu Z. Functional nanomaterials for phototherapies of cancer. Chem. Rev. 114(21), 10869–10939 (2014). • Comprehensive review covering the utilization of nanomaterials for cancer photothermal and photodynamic therapies.
  Medline CASGoogle Scholar
• 2 Vogel A, Venugopalan V. Mechanisms of pulsed laser ablation of biological tissues. Chem. Rev. 103(2), 577–644 (2003).
  Medline CASGoogle Scholar
• 3 Dreaden EC, Mackey MA, Huang X, Kang B, El-Sayed MA. Beating cancer in multiple ways using nanogold. Chem. Soc. Rev. 40(7), 3391–3404 (2011).
  Medline CASGoogle Scholar
• 4 Cheng L, Yang K, Chen Q, Liu Z. Organic stealth nanoparticles for highly effective in vivo near-infrared photothermal therapy of cancer. ACS Nano 6(6), 5605–5613 (2012).
  Medline CASGoogle Scholar
• 5 Wang Y, Black KC, Luehmann H et al. Comparison study of gold nanohexapods, nanorods, and nanocages for photothermal cancer treatment. ACS Nano 7(3), 2068–2077 (2013).
  Medline CASGoogle Scholar
• 6 Zhang B, Wang H, Shen S et al. Fibrin-targeting peptide CREKA-conjugated multi-walled carbon nanotubes for self-amplified photothermal therapy of tumor. Biomaterials 79, 46–55 (2016).
  Medline CASGoogle Scholar
• 7 Liu Z, Liu J, Wang R, Du Y, Ren J, Qu X. An efficient nano-based theranostic system for multi-modal imaging-guided photothermal sterilization in gastrointestinal tract. Biomaterials 56, 206–218 (2015).
  Medline CASGoogle Scholar
• 8 Liu Z, Liu X, Ran X, Ju E, Ren J, Qu X. Single-layer tungsten oxide as intelligent photo-responsive nanoagents for permanent male sterilization. Biomaterials 69, 56–64 (2015).
  Medline CASGoogle Scholar
• 9 Liu Z, Liu X, Du Y, Ren J, Qu X. Using plasmonic copper sulfide nanocrystals as smart light-driven sterilants. ACS Nano 9(10), 10335–10346 (2015).
  Medline CASGoogle Scholar
• 10 Jang C, Lee JH, Sahu A, Tae G. The synergistic effect of folate and RGD dual ligand of nanographene oxide on tumor targeting and photothermal therapy in vivo. Nanoscale 7(44), 18584–18594 (2015).
  Medline CASGoogle Scholar
• 11 Dreyer DR, Todd AD, Bielawski CW. Harnessing the chemistry of graphene oxide. Chem. Soc. Rev. 43(15), 5288–5301 (2014).
  Medline CASGoogle Scholar
• 12 Fazaeli Y, Akhavan O, Rahighi R, Aboudzadeh MR, Karimi E, Afarideh H. In vivo SPECT imaging of tumors by ^198,199Au-labeled graphene oxide nanostructures. Mater. Sci. Eng. C 45, 196–204 (2014).
  Medline CASGoogle Scholar
• 13 Yang K, Zhang S, Zhang G, Sun X, Lee S-T, Liu Z. Graphene in mice: ultrahigh in vivo tumor uptake and efficient photothermal therapy. Nano Lett. 10(9), 3318–3323 (2010). • Pioneering work describing the in vivo photothermal capacity of PEGylated nanographene oxide.
  Medline CASGoogle Scholar
• 14 Bitounis D, Ali-Boucetta H, Hong BH, Min DH, Kostarelos K. Prospects and challenges of graphene in biomedical applications. Adv. Mater. 25(16), 2258–2268 (2013).
  Medline CASGoogle Scholar
• 15 Sun X, Liu Z, Welsher K et al. Nano-graphene oxide for cellular imaging and drug delivery. Nano Res. 1(3), 203–212 (2008).
  Medline CASGoogle Scholar
• 16 Shen H, Liu M, He H et al. PEGylated graphene oxide-mediated protein delivery for cell function regulation. ACS Appl. Mater. Interfaces 4(11), 6317–6323 (2012).
  Medline CASGoogle Scholar
• 17 Krishna KV, Ménard-Moyon C, Verma S, Bianco A. Graphene-based nanomaterials for nanobiotechnology and biomedical applications. Nanomedicine 8(10), 1669–1688 (2013). • Comprehensive review detailing the application of graphene-based nanomaterials in tissue engineering, cancer therapy, sensing and imaging.
  CASGoogle Scholar
• 18 Yang K, Wan J, Zhang S, Tian B, Zhang Y, Liu Z. The influence of surface chemistry and size of nanoscale graphene oxide on photothermal therapy of cancer using ultra-low laser power. Biomaterials 33(7), 2206–2214 (2012).
  Medline CASGoogle Scholar
• 19 Xu H, Fan M, Elhissi AMA et al. PEGylated graphene oxide for tumor-targeted delivery of paclitaxel. Nanomedicine 10(8), 1247–1262 (2015).
  CASGoogle Scholar
• 20 Lee JH, Sahu A, Jang C, Tae G. The effect of ligand density on in vivo tumor targeting of nanographene oxide. J. Control. Release 209, 219–228 (2015).
  Medline CASGoogle Scholar
• 21 Robinson JT, Tabakman SM, Liang Y et al. Ultrasmall reduced graphene oxide with high near-infrared absorbance for photothermal therapy. J. Am. Chem. Soc. 133(17), 6825–6831 (2011). • Research article describing the therapeutic potential of reduced nanographene oxide.
  Medline CASGoogle Scholar
• 22 Akhavan O, Ghaderi E, Emamy H. Nontoxic concentrations of PEGylated graphene nanoribbons for selective cancer cell imaging and photothermal therapy. J. Mater. Chem. 22(38), 20626–20633 (2012).
  CASGoogle Scholar
• 23 Zhang L, Wang Z, Lu Z et al. PEGylated reduced graphene oxide as a superior ssRNA delivery system. J. Mater. Chem. B 1(6), 749–755 (2013).
  CASGoogle Scholar
• 24 Akhavan O, Ghaderi E. Graphene nanomesh promises extremely efficient in vivo photothermal therapy. Small 9(21), 3593–3601 (2013).
  Medline CASGoogle Scholar
• 25 Akhavan O, Meidanchi A, Ghaderi E, Khoei S. Zinc ferrite spinel-graphene in magneto-photothermal therapy of cancer. J. Mater. Chem. B 2(21), 3306–3314 (2014).
  CASGoogle Scholar
• 26 Zhang Z, Tan S, Feng S-S, Vitamin E. TPGS as a molecular biomaterial for drug delivery. Biomaterials 33(19), 4889–4906 (2012). • Comprehensive review describing the diverse applications of D-α-tocopheryl polyethylene glycol 1000 succinate in cancer therapy.
  Medline CASGoogle Scholar
• 27 Zhu D, Tao W, Zhang H et al. Docetaxel (DTX)-loaded polydopamine-modified TPGS-PLA nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Acta Biomater. 30, 144–154 (2016).
  Medline CASGoogle Scholar
• 28 Kutty RV, Chia SL, Setyawati MI, Muthu MS, Feng S-S, Leong DT. In vivo and ex vivo proofs of concept that cetuximab conjugated vitamin E TPGS micelles increases efficacy of delivered docetaxel against triple negative breast cancer. Biomaterials 63, 58–69 (2015).
  Medline CASGoogle Scholar
• 29 Tao W, Zhang J, Zeng X et al. Blended nanoparticle system based on miscible structurally similar polymers: a safe, simple, targeted, and surprisingly high efficiency vehicle for cancer therapy. Adv. Healthcare Mater. 4(8), 1203–1214 (2015).
  Medline CASGoogle Scholar
• 30 Mi Y, Zhao J, Feng S-S. Targeted co-delivery of docetaxel, cisplatin and herceptin by vitamin E TPGS-cisplatin prodrug nanoparticles for multimodality treatment of cancer. J. Control. Release 169(3), 185–192 (2013).
  Medline CASGoogle Scholar
• 31 Zhao J, Mi Y, Feng S-S. Targeted co-delivery of docetaxel and siPlk1 by herceptin-conjugated vitamin E TPGS-based immunomicelles. Biomaterials 34(13), 3411–3421 (2013).
  Medline CASGoogle Scholar
• 32 De Melo-Diogo D, Gaspar VM, Costa EC et al. Combinatorial delivery of crizotinib–palbociclib–sildenafil using TPGS-PLA micelles for improved cancer treatment. Eur. J. Pharm. Biopharm. 88(3), 718–729 (2014).
  Medline CASGoogle Scholar
• 33 Muthu MS, Avinash Kulkarni S, Liu Y, Feng S-S. Development of docetaxel-loaded vitamin E TPGS micelles: formulation optimization, effects on brain cancer cells and biodistribution in rats. Nanomedicine 7(3), 353–364 (2012).
  CASGoogle Scholar
• 34 Gaspar VM, Moreira AF, Costa EC et al. Gas-generating TPGS-PLGA microspheres loaded with nanoparticles (NIMPS) for co-delivery of minicircle DNA and anti-tumoral drugs. Colloids Surf. B 134, 287–294 (2015).
  Medline CASGoogle Scholar
• 35 Tian G, Zheng X, Zhang X et al. TPGS-stabilized NaYbF4: Er upconversion nanoparticles for dual-modal fluorescent/CT imaging and anticancer drug delivery to overcome multi-drug resistance. Biomaterials 40, 107–116 (2015).
  Medline CASGoogle Scholar
• 36 Singh RP, Sharma G, Singh S et al. Vitamin E TPGS conjugated carbon nanotubes improved efficacy of docetaxel with safety for lung cancer treatment. Colloids Surf. B 141, 429–442 (2016).
  Medline CASGoogle Scholar
• 37 Duhem N, Danhier F, Préat V. Vitamin E-based nanomedicines for anti-cancer drug delivery. J. Control. Release 182, 33–44 (2014).
  Medline CASGoogle Scholar
• 38 Neophytou CM, Constantinou C, Papageorgis P, Constantinou AI. D-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in survivin-overexpressing breast cancer cells. Biochem. Pharmacol. 89(1), 31–42 (2014). • Research article describing the effect of D-α-tocopheryl polyethylene glycol 1000 succinate in breast cancer cells.
  Medline CASGoogle Scholar
• 39 Huang NM, Lim HN, Chia CH, Yarmo MA, Muhamad MR. Simple room-temperature preparation of high-yield large-area graphene oxide. Int. J. Nanomed. 6, 3443–3448 (2011).
  Medline CASGoogle Scholar
• 40 Thomas HR, Day SP, Woodruff WE et al. Deoxygenation of graphene oxide: reduction or cleaning? Chem. Mater. 25(18), 3580–3588 (2013).
  CASGoogle Scholar
• 41 Antaris AL, Robinson JT, Yaghi OK et al. Ultra-low doses of chirality sorted (6, 5) carbon nanotubes for simultaneous tumor imaging and photothermal therapy. ACS Nano 7(4), 3644–3652 (2013).
  Medline CASGoogle Scholar
• 42 Chen J, Wang X, Chen T. Facile and green reduction of covalently PEGylated nanographene oxide via a ‘water-only'route for high-efficiency photothermal therapy. Nanoscale Res. Lett. 9(1), 86 (2014).
  MedlineGoogle Scholar
• 43 Gaspar VM, Baril P, Costa EC et al. Bioreducible poly(2-ethyl-2-oxazoline)–PLA–PEI-SS triblock copolymer micelles for co-delivery of DNA minicircles and Doxorubicin. J. Control. Release 213, 175–191 (2015).
  Medline CASGoogle Scholar
• 44 Gaspar VM, Gonçalves C, De Melo-Diogo D et al. Poly(2-ethyl-2-oxazoline)–PLA-g–PEI amphiphilic triblock micelles for co-delivery of minicircle DNA and chemotherapeutics. J. Control. Release 189, 90–104 (2014).
  Medline CASGoogle Scholar
• 45 Mou J, Li P, Liu C et al. Ultrasmall Cu2-xS nanodots for highly efficient photoacoustic imaging-guided photothermal therapy. Small 11(19), 2275–2283 (2015).
  Medline CASGoogle Scholar
• 46 Coluci VR, Martinez DSFT, HonóRio JG et al. Noncovalent interaction with graphene oxide: the crucial role of oxidative debris. J. Phys. Chem. C 118(4), 2187–2193 (2014).
  CASGoogle Scholar
• 47 Ma D, Dong L, Zhou M, Zhu L. The influence of oxidation debris containing in graphene oxide on the adsorption and electrochemical properties of 1,10-phenanthroline-5,6-dione. Analyst 141(9), 2761–2766 (2016).
  Medline CASGoogle Scholar
• 48 Kulkarni SA, Feng S-S. Effects of particle size and surface modification on cellular uptake and biodistribution of polymeric nanoparticles for drug delivery. Pharm. Res. 30(10), 2512–2522 (2013).
  Medline CASGoogle Scholar
• 49 Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nat. Rev. Cancer 14(3), 199–208 (2014).
  Medline CASGoogle Scholar
• 50 Kiew SF, Kiew LV, Lee HB, Imae T, Chung LY. Assessing biocompatibility of graphene oxide-based nanocarriers: a review. J. Control. Release 226, 217–228 (2016).
  Medline CASGoogle Scholar
• 51 Akhavan O, Ghaderi E, Emamy H, Akhavan F. Genotoxicity of graphene nanoribbons in human mesenchymal stem cells. Carbon 54, 419–431 (2013).
  CASGoogle Scholar
• 52 Akhavan O, Ghaderi E, Akhavan A. Size-dependent genotoxicity of graphene nanoplatelets in human stem cells. Biomaterials 33(32), 8017–8025 (2012).
  Medline CASGoogle Scholar
• 53 Zhang H, Peng C, Yang J et al. Uniform ultrasmall graphene oxide nanosheets with low cytotoxicity and high cellular uptake. ACS Appl. Mater. Interfaces 5(5), 1761–1767 (2013).
  Medline CASGoogle Scholar
• 54 Chang Y, Yang S-T, Liu J-H et al. In vitro toxicity evaluation of graphene oxide on A549 cells. Toxicol. Lett. 200(3), 201–210 (2011).
  Medline CASGoogle Scholar
• 55 Pattammattel A, Williams CL, Pande P, Tsui WG, Basu AK, Kumar CV. Biological relevance of oxidative debris present in as-prepared graphene oxide. RSC Adv. 5(73), 59364–59372 (2015).
  Medline CASGoogle Scholar
• 56 Cheng C, Nie S, Li S et al. Biopolymer functionalized reduced graphene oxide with enhanced biocompatibility via mussel inspired coatings/anchors. J. Mater. Chem. B 1(3), 265–275 (2013).
  Medline CASGoogle Scholar
• 57 Akhavan O, Ghaderi E, Aghayee S, Fereydooni Y, Talebi A. The use of a glucose-reduced graphene oxide suspension for photothermal cancer therapy. J. Mater. Chem. 22(27), 13773–13781 (2012).
  CASGoogle Scholar
• 58 Khare V, Sakarchi WA, Gupta PN, Curtis AD, Hoskins C. Synthesis and characterization of TPGS–gemcitabine prodrug micelles for pancreatic cancer therapy. RSC Adv. 6(65), 60126–60137 (2016).
  CASGoogle Scholar
• 59 Yu P, Yu H, Guo C et al. Reversal of doxorubicin resistance in breast cancer by mitochondria-targeted pH-responsive micelles. Acta Biomater. 14, 115–124 (2015).
  Medline CASGoogle Scholar
• 60 Bernabeu E, Gonzalez L, Cagel M, Gergic EP, Moretton MA, Chiappetta DA. Novel Soluplus^®–TPGS mixed micelles for encapsulation of paclitaxel with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines. Colloids Surf. B 140, 403–411 (2016).
  Medline CASGoogle Scholar
• 61 Bao Y, Yin M, Hu X et al. A safe, simple and efficient doxorubicin prodrug hybrid micelle for overcoming tumor multidrug resistance and targeting delivery. J. Control. Release 235, 182–194 (2016).
  Medline CASGoogle Scholar
• 62 Salvati A, Pitek AS, Monopoli MP et al. Transferrin-functionalized nanoparticles lose their targeting capabilities when a biomolecule corona adsorbs on the surface. Nat. Nanotechnol. 8(2), 137–143 (2013).
  Medline CASGoogle Scholar
• 63 Bani F, Adeli M, Movahedi S, Sadeghizadeh M. Graphene-polyglycerol-curcumin hybrid as a near-infrared (NIR) laser stimuli-responsive system for chemo-photothermal cancer therapy. RSC Adv. 6(66), 61141–61149 (2016).
  CASGoogle Scholar
• 64 Kim SH, Lee JE, Sharker SM, Jeong JH, In I, Park SY. In vitro and in vivo tumor targeted photothermal cancer therapy using functionalized graphene nanoparticles. Biomacromolecules 16(11), 3519–3529 (2015).
  Medline CASGoogle Scholar
• 65 Tran TH, Nguyen HT, Pham TT et al. Development of a graphene oxide nanocarrier for dual-drug chemo-phototherapy to overcome drug resistance in cancer. ACS Appl. Mater. Interfaces 7(51), 28647–28655 (2015).
  Medline CASGoogle Scholar
• 66 Markovic ZM, Harhaji-Trajkovic LM, Todorovic-Markovic BM et al. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes. Biomaterials 32(4), 1121–1129 (2011).
  Medline CASGoogle Scholar
• 67 Qin X, Guo Z, Liu Z, Zhang W, Wan M, Yang B. Folic acid-conjugated graphene oxide for cancer targeted chemo-photothermal therapy. J. Photochem. Photobiol., B 120, 156–162 (2013).
  Medline CASGoogle Scholar
• 68 Zhang W, Guo Z, Huang D, Liu Z, Guo X, Zhong H. Synergistic effect of chemo-photothermal therapy using PEGylated graphene oxide. Biomaterials 32(33), 8555–8561 (2011).
  Medline CASGoogle Scholar
• 69 Yang H-W, Lu Y-J, Lin K-J et al. EGRF conjugated PEGylated nanographene oxide for targeted chemotherapy and photothermal therapy. Biomaterials 34(29), 7204–7214 (2013).
  Medline CASGoogle Scholar